Sector Report

This report covers the valuation history of the CDMO and CRO Industry over the last 5 years. During this time, CDMO multiples continue to hit record highs as companies pursue consolidation in an effort to become full-service providers. Similarly, CRO multiples remain at historically elevated levels with sponsors continuing to look toward outsourcing as pharma companies find it increasingly difficult to navigate the regulatory landscape.

For additional research in the CRO and CDMO spaces, please review our full sector snapshots.